Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 2:09 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View All Commentary (AMLN)
Recs
Gr8Vette (92.46) Submitted: 9/15/06 6:08 PM : Start Price: $44.75 AMLN Score: 47.28
One horse show with Byetta. Has had its run up from $16/share to $47/share.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK